Parnassia Groep
Rotterdam, Netherlands
Treatment & access
- Treatments offeredEsketamine nasal spray (Spravato®)
- Access routeCovered by a national programme
- Cost & coverage (registry status)Reimbursed via Dutch basic health insurance (esketamine nasal spray for TRD)
- ReimbursementMember of Esketamine Neusspray Consortium (ENC-NL); esketamine covered per ENC-NL protocol How reimbursement works in Europe →
- Phone+31 88 358 50 50
- Websitehttps://anteszorg.nl/depressie/behandeling/esketamine-neusspray
Related listings
These records belong to the same organisation. They are listed separately because each is a distinct programme or location.
- Another programme at this clinicAntes : Spravato®
About this provider
Within Parnassia Groep, the esketamine nasal spray programme runs from the psychopharmacology outpatient clinic of Antes, the group's Rotterdam organisation. Access is referral-only: the referring clinician first checks whether the patient meets the criteria for treatment-resistant depression, then submits the case to the clinic, where the lead practitioner makes the final eligibility assessment. Patients stay with their own treatment team; esketamine is delivered alongside the existing care plan. In the first four to six weeks patients attend twice a week; treatment continues only with clear improvement, then at most once a week, with effect evaluated regularly at the clinic.
Services & programs
- Esketamine nasal spray (Spravato) outpatient treatment at the Antes psychopharmacology clinic in Rotterdam
- Eligibility assessment of referred patients before treatment starts
- Esketamine delivered alongside the patient's existing treatment team, with regular effect evaluation at the clinic
- Electroconvulsive therapy (ECT) for depression
- Depression research programme, including structured data collection on oral esketamine and, since 2022, intranasal esketamine treatment
Common questions
How do I get access to esketamine treatment at Parnassia Groep (Antes)?
Sign-up is only possible via a referrer. Your own clinician decides whether you may qualify and submits you to the Antes clinic, where the final assessment is made. If approved, you receive detailed information, which is then reviewed together with you before treatment starts. You remain in treatment with your own clinician throughout.
What does the treatment schedule look like?
In the first four to six weeks you come to the outpatient clinic twice a week. Treatment is continued only if there is clear improvement; after that at most one session per week is needed. How long treatment continues is decided together with you and your referrer.
Who is not eligible?
The treatment requires a treatment-resistant depression (insufficient response to at least three treatment trajectories with different antidepressants). Exclusions listed by Antes: pregnancy, (strongly) elevated blood pressure, a bipolar disorder diagnosis, or a heart attack or stroke less than six weeks ago.
Is the treatment reimbursed?
Yes. Esketamine nasal spray is a registered treatment reimbursed by health insurers; nationally it has been part of the basic insurance package since 1 September 2021 for treatment-resistant unipolar depression.
11 more verified providers within 50 km
- Delft · 11 kmGGZ Delfland : Spravato®
- Den Haag · 21 kmPsyQ : Spravato®
- Alphen aan den Rijn · 24 kmSanctuary Kliniek : Spravato®
Practical details
As stated on the provider's own website (checked 2026-09-09); details can change — confirm when you book.
- BookingReferral required — the provider states access runs via a clinician's referral. Source →
Verification
- License / registryLRZa (Landelijk Register Zorgaanbieders, CIBG) — Parnassia Groep B.V., KvK 24417607; ENC-NL esketamine network member
- Official registryhttps://zoeken.zorgaanbiedersportaal.nl/zorgaanbieder/Parnassia%20Groep%20B.V./24417607
- Provider websitehttps://anteszorg.nl/depressie/behandeling/esketamine-neusspray
- Independent sourcehttps://enc-nl.nl/
- Last verified
Check your fit & enquire
Check my fit & enquireWhat to prepare before you enquire
- A referral or the contact details of your treating clinician
- A list of medications you have tried (names, doses, duration)
- A short diagnosis summary or discharge letters